Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT04627233
Eligibility Criteria:
Inclusion Criteria:
* Patients hospitalized with a positive SARS-CoV-2 PCR test and presenting with one or more clear clinical symptoms of COVID-19 disease
* No contraindication to HEP-1
* Obtained informed consent
Exclusion Criteria:
* Patients who had received any immuno-modulator therapy
* Active or chronic kidney/ liver diseases,
* Oncological diseases
* Other viral infection including HIV and hepatitis.
* Any allergic reaction or sensitivity to HEP-1
* Breast feeding or pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04627233
Study Brief:
Protocol Section:
NCT04627233